Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists.

[1]  B. Zimmermann,et al.  Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents , 2008 .

[2]  M. D’Agostino,et al.  Lichenoid reaction induced by adalimumab , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  M. Battistella,et al.  Lichen planus associated with etanercept , 2007, The British journal of dermatology.

[4]  P. Voulgari,et al.  Granuloma annulare induced by anti-tumour necrosis factor therapy , 2007, Annals of the rheumatic diseases.

[5]  G. Haroske,et al.  Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata , 2008 .

[6]  S. Hsu,et al.  Acneiform eruption following anti-TNF-alpha treatment: a report of three cases. , 2008, Journal of drugs in dermatology : JDD.

[7]  M. Khamashta,et al.  Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases , 2007, Medicine.

[8]  D. Staumont-Sallé,et al.  Manifestations cutanées observées au cours d’un traitement par anti-TNF alpha : 11 observations , 2007 .

[9]  W. Sterry,et al.  Cutaneous side‐effects in patients with rheumatic diseases during application of tumour necrosis factor‐α antagonists , 2007, The British journal of dermatology.

[10]  D. Fiorentino.  The Yin and Yang of TNF-α Inhibition , 2007 .

[11]  D. K. Marsee,et al.  Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab. , 2007, Gastroenterology.

[12]  M. Martinka,et al.  Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. , 2007, Archives of dermatology.

[13]  N. Yarom.  Etanercept for the Management of Oral Lichen Planus , 2007, American journal of clinical dermatology.

[14]  A. Taïeb,et al.  Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis. , 2007, Acta dermato-venereologica.

[15]  M. Bandt,et al.  Vasculitides induced by TNFα antagonists: a study in 39 patients in France , 2006 .

[16]  C. Ritchlin,et al.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents , 2006, Annals of the rheumatic diseases.

[17]  T. Bieber,et al.  Type I interferon‐associated cytotoxic inflammation in lichen planus , 2006, Journal of cutaneous pathology.

[18]  W. Bowles,et al.  Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. , 2006, Oral diseases.

[19]  K. Thongprasom,et al.  Expression of TNF-alpha in oral lichen planus treated with fluocinolone acetonide 0.1%. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  A. Gaspari,et al.  Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. , 2006, Archives of dermatology.

[21]  M. Cornelissen,et al.  Lichen planus is associated with human herpesvirus type 7 replication and infiltration of plasmacytoid dendritic cells , 2006, The British journal of dermatology.

[22]  P. C. van de Kerkhof,et al.  Etanercept‐induced lichenoid reaction pattern in psoriasis , 2006, The Journal of dermatological treatment.

[23]  P. V. van Riel,et al.  Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study , 2005, Arthritis research & therapy.

[24]  W. Vermi,et al.  Recruitment of dendritic cells in oral lichen planus , 2005, The Journal of pathology.

[25]  Gordana Brumini,et al.  Salivary levels of tumor necrosis factor-alpha in oral lichen planus. , 2004, Mediators of inflammation.

[26]  E. Fonseca,et al.  Psoriasiform Eruption Induced by Infliximab , 2004, The Annals of pharmacotherapy.

[27]  M. Carrozzo,et al.  Tumor Necrosis Factor-α and Interferon-γ Polymorphisms Contribute to Susceptibility to Oral Lichen Planus , 2004 .

[28]  A. Kızıltunç,et al.  Increased Serum Levels of Tumor Necrosis Factor Alpha in Lichen planus , 2004, Dermatology.

[29]  M. De Vos,et al.  Adverse Skin Reactions to Anti-TNF-Alpha Monoclonal Antibody Therapy , 2003, Dermatology.

[30]  J. S. Pinto,et al.  Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis. , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[31]  I. Betlloch,et al.  Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. , 2002, Archives of dermatology.

[32]  A. H. Saval,et al.  Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma. , 1999 .

[33]  T. Luger,et al.  Ornpharyngeal lichen planus associated with interferon‐α treatment for mycosis fungoides: a rare side‐effect in the therapy of cutaneous lymphomas , 1997, The British journal of dermatology.

[34]  L. From,et al.  Lymphocyte and Macrophage Subsets in Active and Inactive Lesions of Lichen Planus , 1993, The American Journal of dermatopathology.